Literature DB >> 568804

Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines.

L C Schenberg, F G Graeff.   

Abstract

In order to study the interactions between serotonergic mechanism and electrical stimulation of the mesencephalic central gray substance, rats were trained to lever-press for terminating aversive electric stimuli applied at the Periaqueductal gray and adjoining tectum of the mesencephalon. Experimental sessions consisted of 40 discrete escape trials of a maximum of 30 sec duration, separated by 30 sec intervals. Dose-effect curves of two tryptamine antagonists, cyproheptadine and methysergide, as well as of the benzodiazepine minor tranquilizer, chlordiazepoxide, on average escape latencies and on frequency distribution of individual latencies were determined. Doses of 3 to 10 mg/kg of cyproheptadine decreased average latencies of escape responding in six of eight rats studied. Doses of 10 and 30 mg/kg of methysergide also facilitated escape responding in one of three rats. In contrast, doses from 1 to 10 mg/kg of chlordiazepoxide, that cause little sedation or ataxia, produced dose-dependent increases in escape latencies. Furthermore, doses of 5.6 and 10 mg/kg of chlordiazepoxide partially blocked escape responding. The facilitatory effects of the tryptamine antagonists suggest that escape behavior is inhibited by brain tryptaminergic mechanisms, whereas the specific depressant effect of chlordiazepoxide on escape from Periaqueductal gray electrical stimulation suggest that this region may be involved in the antianxiety action of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568804     DOI: 10.1016/0091-3057(78)90287-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Neurochemical changes associated with the action of acute administration of diazepam in reversing the behavioral paradigm conditioned emotional response (CER).

Authors:  J D Lane
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

2.  5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

Authors:  F Jenck; C L Broekkamp; A M Van Delft
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Acquisition of Pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure.

Authors:  Eloisa Pavesi; Newton S Canteras; Antônio P Carobrez
Journal:  Neuropsychopharmacology       Date:  2011-01-05       Impact factor: 7.853

5.  Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.

Authors:  Valquíria Camin de Bortoli; Regina Lúcia Nogueira; Hélio Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  2005-10-29       Impact factor: 4.530

6.  Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats.

Authors:  Vivian Taciany Bonassoli; Ewandro Braz Contardi; Humberto Milani; Rúbia Maria Weffort de Oliveira
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

7.  Opposite effects of chlordiazepoxide and serotonin receptor antagonists on morphine-induced locomotor stimulation in mice.

Authors:  M Sansone
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Anti-aversive role of serotonin in the dorsal periaqueductal grey matter.

Authors:  M T Schütz; J C de Aguiar; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Chlordiazepoxide antinociception: cross-tolerance with opiates and with stress.

Authors:  R J Bodnar; D D Kelly; L W Thomas; A Mansour; M Brutus; M Glusman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.